Condition
Paranasal Sinus Diseases
Total Trials
3
Recruiting
0
Active
0
Completed
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
Termination Rate
0.0%
0 terminated out of 3 trials
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
2Total
Not Applicable (1)
P 2 (1)
Trial Status
Unknown2
Withdrawn1
Clinical Trials (3)
Showing 3 of 3 trials
NCT04968561UnknownPrimary
Design of an Augmented Reality System by Integration of CT Scan or MRI Data With Endoscopic Images for Video-assisted Endonasal Endoscopic Surgery
NCT01814618Phase 2Withdrawn
Trial of Directed High-dose Nasal Steroids on Residual Smell Loss in Sinus Patients After Sinus Surgery
NCT02591524Not ApplicableUnknown
Upper and Lower Airway Colonization in Cystic Fibrosis Patients After Lung Transplantation
Showing all 3 trials